Re: Ethics Approval?
|
2
|
Resverlogix Corp.
|
Oct 12, 2021 06:12PM
|
Re: Eversana ValuationCaseStudy
|
2
|
Resverlogix Corp.
|
Jan 04, 2022 02:32PM
|
Re: Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 07, 2022 04:36PM
|
Re: Excerpt of a recent Bloomberg article......
|
6
|
Resverlogix Corp.
|
Jan 15, 2020 03:11PM
|
Re: Excerpt of a recent Bloomberg article......
|
2
|
Resverlogix Corp.
|
Jan 15, 2020 06:22PM
|
Re: Exempt Distribution - 2022-04-14
|
4
|
Resverlogix Corp.
|
Apr 18, 2022 06:50PM
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 09:42AM
|
Re: Fair warning to everyone here....
|
4
|
Resverlogix Corp.
|
Jun 25, 2019 11:23AM
|
Re: FDA
|
8
|
Resverlogix Corp.
|
Sep 30, 2019 02:11PM
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
2
|
Resverlogix Corp.
|
Mar 15, 2020 03:27PM
|
Re: FDA Timeframe
|
4
|
Resverlogix Corp.
|
Jan 26, 2020 03:07PM
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Mar 29, 2020 06:06PM
|
Re: Finance
|
2
|
Resverlogix Corp.
|
May 25, 2020 02:48PM
|
Re: Financial Clues to the RVX Puzzle
|
3
|
Resverlogix Corp.
|
Mar 14, 2020 11:16AM
|
Re: Financial Statements
|
4
|
Resverlogix Corp.
|
Jul 28, 2020 06:02PM
|
Re: Financial Statements
|
3
|
Resverlogix Corp.
|
Jul 28, 2020 06:39PM
|
Re: Financials and MD&A is out
|
4
|
Resverlogix Corp.
|
Mar 13, 2020 10:45PM
|
Re: Financials and MD&A is out
|
6
|
Resverlogix Corp.
|
Mar 14, 2020 02:59AM
|
Re: Financing May 12-17
|
5
|
Resverlogix Corp.
|
Jun 12, 2021 05:18PM
|
Re: From $4.57 to $3.22....
|
5
|
Resverlogix Corp.
|
Jun 05, 2019 01:47AM
|